Pulmonary hypertension ... in managing PH. "High altitudes reduce oxygen levels in the air, exacerbating symptoms of PH. Be ...

Weak: only small or nonrandomized trials available; Unknown: not enough data to determine benefit. ERA: Endothelin receptor antagonist; PDE5: Phosphodiesterase type 5; PH: Pulmonary hypertension.

Pulmonary arterial hypertension (PAH ... offers new hope for high-risk patients despite receiving maximal background therapy for PAH. It has just demonstrated the efficacy of sotatercept, a ...